|
Volumn 8, Issue 4, 2007, Pages 290-
|
Satraplatin for hormone-refractory prostate cancer.
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;
PLATINUM COMPLEX;
SATRAPLATIN;
ARTICLE;
CHEMICALLY INDUCED DISORDER;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DISEASE COURSE;
DISEASE FREE SURVIVAL;
DRUG RESISTANCE;
HUMAN;
MALE;
NAUSEA;
NEUTROPENIA;
PROSTATE TUMOR;
RANDOMIZED CONTROLLED TRIAL;
THROMBOCYTOPENIA;
VOMITING;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC AGENTS, HORMONAL;
DISEASE PROGRESSION;
DISEASE-FREE SURVIVAL;
DRUG RESISTANCE, NEOPLASM;
HUMANS;
MALE;
NAUSEA;
NEUTROPENIA;
ORGANOPLATINUM COMPOUNDS;
PROSTATIC NEOPLASMS;
RANDOMIZED CONTROLLED TRIALS;
THROMBOCYTOPENIA;
VOMITING;
|
EID: 34247636068
PISSN: 14702045
EISSN: None
Source Type: Journal
DOI: 10.1016/S1470-2045(07)70096-7 Document Type: Article |
Times cited : (5)
|
References (0)
|